Author: George Daley

iPS cells: A promising new platform for drug discovery

Within five years, likely well before we start treating patients with their own genetically corrected stem cells created from induced pluripotent stem cells, I am expecting to see new drugs discovered using iPS cells enter the clinical pipeline.

It’s only been two years since three labs (ours included) created the first human iPS cells through genetic reprogramming of skin cells.

Read Full Story | 2 Comments | Leave a Comment